North America Analysis
Home Search

Stem cell gene therapy - search results

If you're not happy with the results, please do another search

The DIDO Project: autoimmune disease therapies research

University of Perugia’s Ursula Grohmann and Antonio Macchiarulo share the work of the DIDO project in understanding cancer and autoimmune disease therapies

Huntington’s disease: Understanding the impact

Jennifer Simpson of the Huntington’s disease Society of America highlights the disease and how there is still a long way to go before it can be truly understood

Type 1 diabetes: A serious chronic disease

University of Oulu’s Professor Riitta Veijola discusses the impact of Type 1 diabetes on society and the challenges associated with tackling the disease
Gynaecologic research: Improving health for women

Gynaecologic research: Improving health for women

Dr. Lisa Halvorson, U.S. National Institutes of Health discusses the importance of gynaecologic research to develop new treatments and keep women healthy
access to innovative medicines

The IMI programmes driving access to innovative medicines

By providing the infrastructure to support drug discovery, the IMI is accelerating access to innovative medicines, as the EFPIA highlights here Innovation is the lifeblood of the pharmaceutical industry, providing us with the potential to cross new therapeutic frontiers to bring novel medicines to market that benefit patients and deliver...
novel nutraceuticals from sardines

ProteoLipins and LipoFishins: Novel nutraceuticals and their effects

Dr Ramón Cacabelos, President of EuroEspes Biomedical Research Center, highlights the potential benefits of novel nutraceuticals including ProteoLipins Pharmacotherapy is a fundamental cornerstone in the global fight against disease worldwide. The value of drug production has grown four times more rapidly than the world’s income. High-income countries dominate in world...
non-coding RNA research cancer lab

Why non-coding RNA research for cancer is key

Jo Vandesompele, Chief Scientific Officer at Biogazelle, outlines how non-coding RNA research for cancer can help develop a more targeted treatment approach  DNA is the hereditary code that is passed on from parents to their children. Every cell inside our body has the same code that contains the blueprint of...

Breast cancer: prevention and survival

Rachel Clark, Health Promotion Manager, at World Cancer Research Fund, sheds light on breast cancer and how to reduce the risks of developing the disease. Breast cancer is the most common cancer in women in the UK. In fact, 1 in 8 women will develop the disease at some stage...

Infectious disease is a global problem

Professor Colin J Suckling, Research Professor of Chemistry at the Department of Pure & Applied Chemistry, University of Strathclyde looks at how the recent EU Referendum could impact his institution and research. Like many British academics, the result of the recent referendum on the UK’s place in Europe was a...

Development of multiple drug resistance (MDR)

Terra G. Arnason and Troy A.A. Harkness from the Departments of Medicine, and Anatomy and Cell Biology at the University of Saskatchewan detail current strategies to prevent or reverse multiple drug resistant malignancy… Multiple drug resistance (MDR) can be present from the outset (inherent) or develop (acquired) in response to...
brain

The brain health challenge: reducing the economic impact

Prof David Nutt, European Brain Council on the economic impact of poor brain health & how they are calling for new thinking towards how it is treated
Cancer

Development of integrated non-invasive methods for cancer diagnosis and treatment

Stuart J. Corr1,2,3, Steven Curley1,4, Zhihui Wang5,6, and Vittorio Cristini5,6 1Department of Surgery, Division of Surgical Research, Baylor College of Medicine, Houston, TX 77030, USA 2Department of Chemistry, Rice University, Houston, TX 77005, USA 3Department of Bioengineering, University of Houston, Houston, TX 77004, USA 4Department of Mechanical Engineering and Materials Science, Rice University,...
biomass

Implementing Bioeconomy with Electrobiorefinery

Food, chemical and industrial sectors are challenged with the growing population, increasing longevity and quality of life. In consequence, the demand for fossils energy sources, agricultural land and drinking water what will lead to irreversible changes in climate with unpredictable consequences. A recent declaration of G7 leaders that in...

Platelets in hemostasis and thrombosis – finding the right balance

Nucleated blood platelets are produced by their bone marrow resident precursors, the megakaryocytes, in a unique process in mammalian physiology. Terminally differentiated, polyploid megakaryocytes are the largest cells in the bone marrow evolving from hematopoietic stem cells. Megakaryocytes are localised in close proximity to sinusoidal blood vessels and convert...
nuclear medicine

Nuclear Medicine in Dusseldorf

The Clinic of Nuclear Medicine at the University Hospital is located both in Düsseldorf and at the Research Center Jülich, and runs a nuclear medical out-patient department covering the whole spectrum of radioisotope scanning from thyroid and skeleton scintigraphy to examinations of amino acid metabolism for tumor diagnosis. As...
RNA

Exon skipping: making sense out of nonsense

Associate Professor Michela Alessandra Denti, Principal Investigator of the Laboratory of RNA Biology and Biotechnology at the Centre for Integrative Biology of the University of Trento, discusses how modulation of RNA splicing can represent a cure for inherited diseases RNA impacts nearly every aspect of gene expression and it is now clear...
NCI

Reducing the burden of cancer

AG highlights the work of the National Cancer Institute (NCI), to reduce and treat cancer. The National Cancer Institute (NCI) is the U.S. Federal government’s primary agency for cancer research and training. As part of the National Institutes of Health (NIH) they coordinate with the National Cancer Programme, which conducts...
HIV

Are we standing in our own way on the path to a cure for...

Although there are many reasons to celebrate the life-extending benefits from antiretroviral therapeutics (ART) for HIV/AIDS and the ability to chronically manage patients’ disease for decades, the majority of people around the world living with the virus do not have access to ART and those that do, have over...
cancer

Tackling cancer in children and adolescents

Professor Giles Vassal, President of the European Society for Paediatric Oncology outlines why it is crucial for Europe to come together and tackle and prevent cancer in children. Compared to the incidence in adults, cancer is rare in children and adolescents but concerns 35,000 young people each year in Europe. Despite...
TU Munich

Liver cancer: Future scientific and clinical challenges and forthcoming problems in Europe

Hepatocellular carcinoma (HCC) reflects the most common primary liver cancer as well as the 2nd most common cause of cancer related death in humans worldwide. In most cases HCC is caused by chronic liver damage that is either induced by chronic viral infections (e.g. Hepatitis B or C viruses),...

Follow Open Access Government